Medical Care
Global CD31 Antibody Market Research Report 2025
- May 12, 25
- ID: 234914
- Pages: 114
- Figures: 111
- Views: 9
The global market for CD31 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CD31 Antibody can be used in a variety of scientific applications, including western blotting, immunohistochemistry, immunocytochemistry, immunoprecipitation, and ELISA. These antibodies target CD31 in human, mouse, rat, rabbit and pig samples.
Growing patient base, launch of novel CD31 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD31 antibody market revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CD31 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD31 Antibody.
The CD31 Antibody market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD31 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD31 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BosterBio
Bio-Rad
Bioss
Thermo Fisher Scientific
NSJ Bioreagents
R and D Systems
Abcam
BioLegend
GeneTex
Novus Biologicals
SouthernBiotech
LifeSpan BioSciences
Enzo Life Sciences
Bethyl Laboratories
Abbexa
ProSci
Proteintech
Synaptic Systems
BIOCARE MEDICAL
CUSABIO Technology
Absolute Antibody
EpiGentek
Biorbyt
Wuhan Fine Biotech
Sino Biological
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Western Blot (WB)
Immunocytochemistry (ICC)
ELISA
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CD31 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CD31 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
CD31 Antibody can be used in a variety of scientific applications, including western blotting, immunohistochemistry, immunocytochemistry, immunoprecipitation, and ELISA. These antibodies target CD31 in human, mouse, rat, rabbit and pig samples.
Growing patient base, launch of novel CD31 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD31 antibody market revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CD31 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD31 Antibody.
The CD31 Antibody market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD31 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD31 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BosterBio
Bio-Rad
Bioss
Thermo Fisher Scientific
NSJ Bioreagents
R and D Systems
Abcam
BioLegend
GeneTex
Novus Biologicals
SouthernBiotech
LifeSpan BioSciences
Enzo Life Sciences
Bethyl Laboratories
Abbexa
ProSci
Proteintech
Synaptic Systems
BIOCARE MEDICAL
CUSABIO Technology
Absolute Antibody
EpiGentek
Biorbyt
Wuhan Fine Biotech
Sino Biological
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Western Blot (WB)
Immunocytochemistry (ICC)
ELISA
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CD31 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CD31 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 CD31 Antibody Market Overview
1.1 Product Definition
1.2 CD31 Antibody by Type
1.2.1 Global CD31 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 CD31 Antibody by Application
1.3.1 Global CD31 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Western Blot (WB)
1.3.5 Immunocytochemistry (ICC)
1.3.6 ELISA
1.3.7 Others
1.4 Global CD31 Antibody Market Size Estimates and Forecasts
1.4.1 Global CD31 Antibody Revenue 2020-2031
1.4.2 Global CD31 Antibody Sales 2020-2031
1.4.3 Global CD31 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 CD31 Antibody Market Competition by Manufacturers
2.1 Global CD31 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global CD31 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global CD31 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of CD31 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CD31 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD31 Antibody, Product Type & Application
2.7 Global Key Manufacturers of CD31 Antibody, Date of Enter into This Industry
2.8 Global CD31 Antibody Market Competitive Situation and Trends
2.8.1 Global CD31 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest CD31 Antibody Players Market Share by Revenue
2.8.3 Global CD31 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global CD31 Antibody Market Scenario by Region
3.1 Global CD31 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global CD31 Antibody Sales by Region: 2020-2031
3.2.1 Global CD31 Antibody Sales by Region: 2020-2025
3.2.2 Global CD31 Antibody Sales by Region: 2026-2031
3.3 Global CD31 Antibody Revenue by Region: 2020-2031
3.3.1 Global CD31 Antibody Revenue by Region: 2020-2025
3.3.2 Global CD31 Antibody Revenue by Region: 2026-2031
3.4 North America CD31 Antibody Market Facts & Figures by Country
3.4.1 North America CD31 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America CD31 Antibody Sales by Country (2020-2031)
3.4.3 North America CD31 Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD31 Antibody Market Facts & Figures by Country
3.5.1 Europe CD31 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe CD31 Antibody Sales by Country (2020-2031)
3.5.3 Europe CD31 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD31 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific CD31 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific CD31 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific CD31 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD31 Antibody Market Facts & Figures by Country
3.7.1 Latin America CD31 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America CD31 Antibody Sales by Country (2020-2031)
3.7.3 Latin America CD31 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD31 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CD31 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa CD31 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa CD31 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD31 Antibody Sales by Type (2020-2031)
4.1.1 Global CD31 Antibody Sales by Type (2020-2025)
4.1.2 Global CD31 Antibody Sales by Type (2026-2031)
4.1.3 Global CD31 Antibody Sales Market Share by Type (2020-2031)
4.2 Global CD31 Antibody Revenue by Type (2020-2031)
4.2.1 Global CD31 Antibody Revenue by Type (2020-2025)
4.2.2 Global CD31 Antibody Revenue by Type (2026-2031)
4.2.3 Global CD31 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global CD31 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global CD31 Antibody Sales by Application (2020-2031)
5.1.1 Global CD31 Antibody Sales by Application (2020-2025)
5.1.2 Global CD31 Antibody Sales by Application (2026-2031)
5.1.3 Global CD31 Antibody Sales Market Share by Application (2020-2031)
5.2 Global CD31 Antibody Revenue by Application (2020-2031)
5.2.1 Global CD31 Antibody Revenue by Application (2020-2025)
5.2.2 Global CD31 Antibody Revenue by Application (2026-2031)
5.2.3 Global CD31 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global CD31 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BosterBio
6.1.1 BosterBio Company Information
6.1.2 BosterBio Description and Business Overview
6.1.3 BosterBio CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BosterBio CD31 Antibody Product Portfolio
6.1.5 BosterBio Recent Developments/Updates
6.2 Bio-Rad
6.2.1 Bio-Rad Company Information
6.2.2 Bio-Rad Description and Business Overview
6.2.3 Bio-Rad CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Rad CD31 Antibody Product Portfolio
6.2.5 Bio-Rad Recent Developments/Updates
6.3 Bioss
6.3.1 Bioss Company Information
6.3.2 Bioss Description and Business Overview
6.3.3 Bioss CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bioss CD31 Antibody Product Portfolio
6.3.5 Bioss Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Company Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Scientific CD31 Antibody Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 NSJ Bioreagents
6.5.1 NSJ Bioreagents Company Information
6.5.2 NSJ Bioreagents Description and Business Overview
6.5.3 NSJ Bioreagents CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 NSJ Bioreagents CD31 Antibody Product Portfolio
6.5.5 NSJ Bioreagents Recent Developments/Updates
6.6 R and D Systems
6.6.1 R and D Systems Company Information
6.6.2 R and D Systems Description and Business Overview
6.6.3 R and D Systems CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 R and D Systems CD31 Antibody Product Portfolio
6.6.5 R and D Systems Recent Developments/Updates
6.7 Abcam
6.7.1 Abcam Company Information
6.7.2 Abcam Description and Business Overview
6.7.3 Abcam CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abcam CD31 Antibody Product Portfolio
6.7.5 Abcam Recent Developments/Updates
6.8 BioLegend
6.8.1 BioLegend Company Information
6.8.2 BioLegend Description and Business Overview
6.8.3 BioLegend CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BioLegend CD31 Antibody Product Portfolio
6.8.5 BioLegend Recent Developments/Updates
6.9 GeneTex
6.9.1 GeneTex Company Information
6.9.2 GeneTex Description and Business Overview
6.9.3 GeneTex CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GeneTex CD31 Antibody Product Portfolio
6.9.5 GeneTex Recent Developments/Updates
6.10 Novus Biologicals
6.10.1 Novus Biologicals Company Information
6.10.2 Novus Biologicals Description and Business Overview
6.10.3 Novus Biologicals CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novus Biologicals CD31 Antibody Product Portfolio
6.10.5 Novus Biologicals Recent Developments/Updates
6.11 SouthernBiotech
6.11.1 SouthernBiotech Company Information
6.11.2 SouthernBiotech Description and Business Overview
6.11.3 SouthernBiotech CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SouthernBiotech CD31 Antibody Product Portfolio
6.11.5 SouthernBiotech Recent Developments/Updates
6.12 LifeSpan BioSciences
6.12.1 LifeSpan BioSciences Company Information
6.12.2 LifeSpan BioSciences Description and Business Overview
6.12.3 LifeSpan BioSciences CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 LifeSpan BioSciences CD31 Antibody Product Portfolio
6.12.5 LifeSpan BioSciences Recent Developments/Updates
6.13 Enzo Life Sciences
6.13.1 Enzo Life Sciences Company Information
6.13.2 Enzo Life Sciences Description and Business Overview
6.13.3 Enzo Life Sciences CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Enzo Life Sciences CD31 Antibody Product Portfolio
6.13.5 Enzo Life Sciences Recent Developments/Updates
6.14 Bethyl Laboratories
6.14.1 Bethyl Laboratories Company Information
6.14.2 Bethyl Laboratories Description and Business Overview
6.14.3 Bethyl Laboratories CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bethyl Laboratories CD31 Antibody Product Portfolio
6.14.5 Bethyl Laboratories Recent Developments/Updates
6.15 Abbexa
6.15.1 Abbexa Company Information
6.15.2 Abbexa Description and Business Overview
6.15.3 Abbexa CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Abbexa CD31 Antibody Product Portfolio
6.15.5 Abbexa Recent Developments/Updates
6.16 ProSci
6.16.1 ProSci Company Information
6.16.2 ProSci Description and Business Overview
6.16.3 ProSci CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 ProSci CD31 Antibody Product Portfolio
6.16.5 ProSci Recent Developments/Updates
6.17 Proteintech
6.17.1 Proteintech Company Information
6.17.2 Proteintech Description and Business Overview
6.17.3 Proteintech CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Proteintech CD31 Antibody Product Portfolio
6.17.5 Proteintech Recent Developments/Updates
6.18 Synaptic Systems
6.18.1 Synaptic Systems Company Information
6.18.2 Synaptic Systems Description and Business Overview
6.18.3 Synaptic Systems CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Synaptic Systems CD31 Antibody Product Portfolio
6.18.5 Synaptic Systems Recent Developments/Updates
6.19 BIOCARE MEDICAL
6.19.1 BIOCARE MEDICAL Company Information
6.19.2 BIOCARE MEDICAL Description and Business Overview
6.19.3 BIOCARE MEDICAL CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 BIOCARE MEDICAL CD31 Antibody Product Portfolio
6.19.5 BIOCARE MEDICAL Recent Developments/Updates
6.20 CUSABIO Technology
6.20.1 CUSABIO Technology Company Information
6.20.2 CUSABIO Technology Description and Business Overview
6.20.3 CUSABIO Technology CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.20.4 CUSABIO Technology CD31 Antibody Product Portfolio
6.20.5 CUSABIO Technology Recent Developments/Updates
6.21 Absolute Antibody
6.21.1 Absolute Antibody Company Information
6.21.2 Absolute Antibody Description and Business Overview
6.21.3 Absolute Antibody CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Absolute Antibody CD31 Antibody Product Portfolio
6.21.5 Absolute Antibody Recent Developments/Updates
6.22 EpiGentek
6.22.1 EpiGentek Company Information
6.22.2 EpiGentek Description and Business Overview
6.22.3 EpiGentek CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.22.4 EpiGentek CD31 Antibody Product Portfolio
6.22.5 EpiGentek Recent Developments/Updates
6.23 Biorbyt
6.23.1 Biorbyt Company Information
6.23.2 Biorbyt Description and Business Overview
6.23.3 Biorbyt CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Biorbyt CD31 Antibody Product Portfolio
6.23.5 Biorbyt Recent Developments/Updates
6.24 Wuhan Fine Biotech
6.24.1 Wuhan Fine Biotech Company Information
6.24.2 Wuhan Fine Biotech Description and Business Overview
6.24.3 Wuhan Fine Biotech CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Wuhan Fine Biotech CD31 Antibody Product Portfolio
6.24.5 Wuhan Fine Biotech Recent Developments/Updates
6.25 Sino Biological
6.25.1 Sino Biological Company Information
6.25.2 Sino Biological Description and Business Overview
6.25.3 Sino Biological CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Sino Biological CD31 Antibody Product Portfolio
6.25.5 Sino Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD31 Antibody Industry Chain Analysis
7.2 CD31 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD31 Antibody Production Mode & Process Analysis
7.4 CD31 Antibody Sales and Marketing
7.4.1 CD31 Antibody Sales Channels
7.4.2 CD31 Antibody Distributors
7.5 CD31 Antibody Customer Analysis
8 CD31 Antibody Market Dynamics
8.1 CD31 Antibody Industry Trends
8.2 CD31 Antibody Market Drivers
8.3 CD31 Antibody Market Challenges
8.4 CD31 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 CD31 Antibody by Type
1.2.1 Global CD31 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 CD31 Antibody by Application
1.3.1 Global CD31 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Western Blot (WB)
1.3.5 Immunocytochemistry (ICC)
1.3.6 ELISA
1.3.7 Others
1.4 Global CD31 Antibody Market Size Estimates and Forecasts
1.4.1 Global CD31 Antibody Revenue 2020-2031
1.4.2 Global CD31 Antibody Sales 2020-2031
1.4.3 Global CD31 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 CD31 Antibody Market Competition by Manufacturers
2.1 Global CD31 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global CD31 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global CD31 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of CD31 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CD31 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD31 Antibody, Product Type & Application
2.7 Global Key Manufacturers of CD31 Antibody, Date of Enter into This Industry
2.8 Global CD31 Antibody Market Competitive Situation and Trends
2.8.1 Global CD31 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest CD31 Antibody Players Market Share by Revenue
2.8.3 Global CD31 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global CD31 Antibody Market Scenario by Region
3.1 Global CD31 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global CD31 Antibody Sales by Region: 2020-2031
3.2.1 Global CD31 Antibody Sales by Region: 2020-2025
3.2.2 Global CD31 Antibody Sales by Region: 2026-2031
3.3 Global CD31 Antibody Revenue by Region: 2020-2031
3.3.1 Global CD31 Antibody Revenue by Region: 2020-2025
3.3.2 Global CD31 Antibody Revenue by Region: 2026-2031
3.4 North America CD31 Antibody Market Facts & Figures by Country
3.4.1 North America CD31 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America CD31 Antibody Sales by Country (2020-2031)
3.4.3 North America CD31 Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD31 Antibody Market Facts & Figures by Country
3.5.1 Europe CD31 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe CD31 Antibody Sales by Country (2020-2031)
3.5.3 Europe CD31 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD31 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific CD31 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific CD31 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific CD31 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD31 Antibody Market Facts & Figures by Country
3.7.1 Latin America CD31 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America CD31 Antibody Sales by Country (2020-2031)
3.7.3 Latin America CD31 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD31 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CD31 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa CD31 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa CD31 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD31 Antibody Sales by Type (2020-2031)
4.1.1 Global CD31 Antibody Sales by Type (2020-2025)
4.1.2 Global CD31 Antibody Sales by Type (2026-2031)
4.1.3 Global CD31 Antibody Sales Market Share by Type (2020-2031)
4.2 Global CD31 Antibody Revenue by Type (2020-2031)
4.2.1 Global CD31 Antibody Revenue by Type (2020-2025)
4.2.2 Global CD31 Antibody Revenue by Type (2026-2031)
4.2.3 Global CD31 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global CD31 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global CD31 Antibody Sales by Application (2020-2031)
5.1.1 Global CD31 Antibody Sales by Application (2020-2025)
5.1.2 Global CD31 Antibody Sales by Application (2026-2031)
5.1.3 Global CD31 Antibody Sales Market Share by Application (2020-2031)
5.2 Global CD31 Antibody Revenue by Application (2020-2031)
5.2.1 Global CD31 Antibody Revenue by Application (2020-2025)
5.2.2 Global CD31 Antibody Revenue by Application (2026-2031)
5.2.3 Global CD31 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global CD31 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BosterBio
6.1.1 BosterBio Company Information
6.1.2 BosterBio Description and Business Overview
6.1.3 BosterBio CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BosterBio CD31 Antibody Product Portfolio
6.1.5 BosterBio Recent Developments/Updates
6.2 Bio-Rad
6.2.1 Bio-Rad Company Information
6.2.2 Bio-Rad Description and Business Overview
6.2.3 Bio-Rad CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Rad CD31 Antibody Product Portfolio
6.2.5 Bio-Rad Recent Developments/Updates
6.3 Bioss
6.3.1 Bioss Company Information
6.3.2 Bioss Description and Business Overview
6.3.3 Bioss CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bioss CD31 Antibody Product Portfolio
6.3.5 Bioss Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Company Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Scientific CD31 Antibody Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 NSJ Bioreagents
6.5.1 NSJ Bioreagents Company Information
6.5.2 NSJ Bioreagents Description and Business Overview
6.5.3 NSJ Bioreagents CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 NSJ Bioreagents CD31 Antibody Product Portfolio
6.5.5 NSJ Bioreagents Recent Developments/Updates
6.6 R and D Systems
6.6.1 R and D Systems Company Information
6.6.2 R and D Systems Description and Business Overview
6.6.3 R and D Systems CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 R and D Systems CD31 Antibody Product Portfolio
6.6.5 R and D Systems Recent Developments/Updates
6.7 Abcam
6.7.1 Abcam Company Information
6.7.2 Abcam Description and Business Overview
6.7.3 Abcam CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abcam CD31 Antibody Product Portfolio
6.7.5 Abcam Recent Developments/Updates
6.8 BioLegend
6.8.1 BioLegend Company Information
6.8.2 BioLegend Description and Business Overview
6.8.3 BioLegend CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BioLegend CD31 Antibody Product Portfolio
6.8.5 BioLegend Recent Developments/Updates
6.9 GeneTex
6.9.1 GeneTex Company Information
6.9.2 GeneTex Description and Business Overview
6.9.3 GeneTex CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GeneTex CD31 Antibody Product Portfolio
6.9.5 GeneTex Recent Developments/Updates
6.10 Novus Biologicals
6.10.1 Novus Biologicals Company Information
6.10.2 Novus Biologicals Description and Business Overview
6.10.3 Novus Biologicals CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novus Biologicals CD31 Antibody Product Portfolio
6.10.5 Novus Biologicals Recent Developments/Updates
6.11 SouthernBiotech
6.11.1 SouthernBiotech Company Information
6.11.2 SouthernBiotech Description and Business Overview
6.11.3 SouthernBiotech CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SouthernBiotech CD31 Antibody Product Portfolio
6.11.5 SouthernBiotech Recent Developments/Updates
6.12 LifeSpan BioSciences
6.12.1 LifeSpan BioSciences Company Information
6.12.2 LifeSpan BioSciences Description and Business Overview
6.12.3 LifeSpan BioSciences CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 LifeSpan BioSciences CD31 Antibody Product Portfolio
6.12.5 LifeSpan BioSciences Recent Developments/Updates
6.13 Enzo Life Sciences
6.13.1 Enzo Life Sciences Company Information
6.13.2 Enzo Life Sciences Description and Business Overview
6.13.3 Enzo Life Sciences CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Enzo Life Sciences CD31 Antibody Product Portfolio
6.13.5 Enzo Life Sciences Recent Developments/Updates
6.14 Bethyl Laboratories
6.14.1 Bethyl Laboratories Company Information
6.14.2 Bethyl Laboratories Description and Business Overview
6.14.3 Bethyl Laboratories CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bethyl Laboratories CD31 Antibody Product Portfolio
6.14.5 Bethyl Laboratories Recent Developments/Updates
6.15 Abbexa
6.15.1 Abbexa Company Information
6.15.2 Abbexa Description and Business Overview
6.15.3 Abbexa CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Abbexa CD31 Antibody Product Portfolio
6.15.5 Abbexa Recent Developments/Updates
6.16 ProSci
6.16.1 ProSci Company Information
6.16.2 ProSci Description and Business Overview
6.16.3 ProSci CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 ProSci CD31 Antibody Product Portfolio
6.16.5 ProSci Recent Developments/Updates
6.17 Proteintech
6.17.1 Proteintech Company Information
6.17.2 Proteintech Description and Business Overview
6.17.3 Proteintech CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Proteintech CD31 Antibody Product Portfolio
6.17.5 Proteintech Recent Developments/Updates
6.18 Synaptic Systems
6.18.1 Synaptic Systems Company Information
6.18.2 Synaptic Systems Description and Business Overview
6.18.3 Synaptic Systems CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Synaptic Systems CD31 Antibody Product Portfolio
6.18.5 Synaptic Systems Recent Developments/Updates
6.19 BIOCARE MEDICAL
6.19.1 BIOCARE MEDICAL Company Information
6.19.2 BIOCARE MEDICAL Description and Business Overview
6.19.3 BIOCARE MEDICAL CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 BIOCARE MEDICAL CD31 Antibody Product Portfolio
6.19.5 BIOCARE MEDICAL Recent Developments/Updates
6.20 CUSABIO Technology
6.20.1 CUSABIO Technology Company Information
6.20.2 CUSABIO Technology Description and Business Overview
6.20.3 CUSABIO Technology CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.20.4 CUSABIO Technology CD31 Antibody Product Portfolio
6.20.5 CUSABIO Technology Recent Developments/Updates
6.21 Absolute Antibody
6.21.1 Absolute Antibody Company Information
6.21.2 Absolute Antibody Description and Business Overview
6.21.3 Absolute Antibody CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Absolute Antibody CD31 Antibody Product Portfolio
6.21.5 Absolute Antibody Recent Developments/Updates
6.22 EpiGentek
6.22.1 EpiGentek Company Information
6.22.2 EpiGentek Description and Business Overview
6.22.3 EpiGentek CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.22.4 EpiGentek CD31 Antibody Product Portfolio
6.22.5 EpiGentek Recent Developments/Updates
6.23 Biorbyt
6.23.1 Biorbyt Company Information
6.23.2 Biorbyt Description and Business Overview
6.23.3 Biorbyt CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Biorbyt CD31 Antibody Product Portfolio
6.23.5 Biorbyt Recent Developments/Updates
6.24 Wuhan Fine Biotech
6.24.1 Wuhan Fine Biotech Company Information
6.24.2 Wuhan Fine Biotech Description and Business Overview
6.24.3 Wuhan Fine Biotech CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Wuhan Fine Biotech CD31 Antibody Product Portfolio
6.24.5 Wuhan Fine Biotech Recent Developments/Updates
6.25 Sino Biological
6.25.1 Sino Biological Company Information
6.25.2 Sino Biological Description and Business Overview
6.25.3 Sino Biological CD31 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Sino Biological CD31 Antibody Product Portfolio
6.25.5 Sino Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD31 Antibody Industry Chain Analysis
7.2 CD31 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD31 Antibody Production Mode & Process Analysis
7.4 CD31 Antibody Sales and Marketing
7.4.1 CD31 Antibody Sales Channels
7.4.2 CD31 Antibody Distributors
7.5 CD31 Antibody Customer Analysis
8 CD31 Antibody Market Dynamics
8.1 CD31 Antibody Industry Trends
8.2 CD31 Antibody Market Drivers
8.3 CD31 Antibody Market Challenges
8.4 CD31 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global CD31 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global CD31 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global CD31 Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global CD31 Antibody Sales (L) of Key Manufacturers (2020-2025)
Table 5. Global CD31 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global CD31 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global CD31 Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market CD31 Antibody Average Price (US$/L) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of CD31 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CD31 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD31 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of CD31 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD31 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD31 Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD31 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global CD31 Antibody Sales by Region (2020-2025) & (L)
Table 18. Global CD31 Antibody Sales Market Share by Region (2020-2025)
Table 19. Global CD31 Antibody Sales by Region (2026-2031) & (L)
Table 20. Global CD31 Antibody Sales Market Share by Region (2026-2031)
Table 21. Global CD31 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global CD31 Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global CD31 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global CD31 Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America CD31 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America CD31 Antibody Sales by Country (2020-2025) & (L)
Table 27. North America CD31 Antibody Sales by Country (2026-2031) & (L)
Table 28. North America CD31 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America CD31 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe CD31 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe CD31 Antibody Sales by Country (2020-2025) & (L)
Table 32. Europe CD31 Antibody Sales by Country (2026-2031) & (L)
Table 33. Europe CD31 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe CD31 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific CD31 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific CD31 Antibody Sales by Region (2020-2025) & (L)
Table 37. Asia Pacific CD31 Antibody Sales by Region (2026-2031) & (L)
Table 38. Asia Pacific CD31 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific CD31 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD31 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America CD31 Antibody Sales by Country (2020-2025) & (L)
Table 42. Latin America CD31 Antibody Sales by Country (2026-2031) & (L)
Table 43. Latin America CD31 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America CD31 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa CD31 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa CD31 Antibody Sales by Country (2020-2025) & (L)
Table 47. Middle East and Africa CD31 Antibody Sales by Country (2026-2031) & (L)
Table 48. Middle East and Africa CD31 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa CD31 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global CD31 Antibody Sales (L) by Type (2020-2025)
Table 51. Global CD31 Antibody Sales (L) by Type (2026-2031)
Table 52. Global CD31 Antibody Sales Market Share by Type (2020-2025)
Table 53. Global CD31 Antibody Sales Market Share by Type (2026-2031)
Table 54. Global CD31 Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global CD31 Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global CD31 Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global CD31 Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global CD31 Antibody Price (US$/L) by Type (2020-2025)
Table 59. Global CD31 Antibody Price (US$/L) by Type (2026-2031)
Table 60. Global CD31 Antibody Sales (L) by Application (2020-2025)
Table 61. Global CD31 Antibody Sales (L) by Application (2026-2031)
Table 62. Global CD31 Antibody Sales Market Share by Application (2020-2025)
Table 63. Global CD31 Antibody Sales Market Share by Application (2026-2031)
Table 64. Global CD31 Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global CD31 Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global CD31 Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global CD31 Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global CD31 Antibody Price (US$/L) by Application (2020-2025)
Table 69. Global CD31 Antibody Price (US$/L) by Application (2026-2031)
Table 70. BosterBio Company Information
Table 71. BosterBio Description and Business Overview
Table 72. BosterBio CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. BosterBio CD31 Antibody Product
Table 74. BosterBio Recent Developments/Updates
Table 75. Bio-Rad Company Information
Table 76. Bio-Rad Description and Business Overview
Table 77. Bio-Rad CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. Bio-Rad CD31 Antibody Product
Table 79. Bio-Rad Recent Developments/Updates
Table 80. Bioss Company Information
Table 81. Bioss Description and Business Overview
Table 82. Bioss CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Bioss CD31 Antibody Product
Table 84. Bioss Recent Developments/Updates
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific CD31 Antibody Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. NSJ Bioreagents Company Information
Table 91. NSJ Bioreagents Description and Business Overview
Table 92. NSJ Bioreagents CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 93. NSJ Bioreagents CD31 Antibody Product
Table 94. NSJ Bioreagents Recent Developments/Updates
Table 95. R and D Systems Company Information
Table 96. R and D Systems Description and Business Overview
Table 97. R and D Systems CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 98. R and D Systems CD31 Antibody Product
Table 99. R and D Systems Recent Developments/Updates
Table 100. Abcam Company Information
Table 101. Abcam Description and Business Overview
Table 102. Abcam CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 103. Abcam CD31 Antibody Product
Table 104. Abcam Recent Developments/Updates
Table 105. BioLegend Company Information
Table 106. BioLegend Description and Business Overview
Table 107. BioLegend CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 108. BioLegend CD31 Antibody Product
Table 109. BioLegend Recent Developments/Updates
Table 110. GeneTex Company Information
Table 111. GeneTex Description and Business Overview
Table 112. GeneTex CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 113. GeneTex CD31 Antibody Product
Table 114. GeneTex Recent Developments/Updates
Table 115. Novus Biologicals Company Information
Table 116. Novus Biologicals Description and Business Overview
Table 117. Novus Biologicals CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 118. Novus Biologicals CD31 Antibody Product
Table 119. Novus Biologicals Recent Developments/Updates
Table 120. SouthernBiotech Company Information
Table 121. SouthernBiotech Description and Business Overview
Table 122. SouthernBiotech CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 123. SouthernBiotech CD31 Antibody Product
Table 124. SouthernBiotech Recent Developments/Updates
Table 125. LifeSpan BioSciences Company Information
Table 126. LifeSpan BioSciences Description and Business Overview
Table 127. LifeSpan BioSciences CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 128. LifeSpan BioSciences CD31 Antibody Product
Table 129. LifeSpan BioSciences Recent Developments/Updates
Table 130. Enzo Life Sciences Company Information
Table 131. Enzo Life Sciences Description and Business Overview
Table 132. Enzo Life Sciences CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 133. Enzo Life Sciences CD31 Antibody Product
Table 134. Enzo Life Sciences Recent Developments/Updates
Table 135. Bethyl Laboratories Company Information
Table 136. Bethyl Laboratories Description and Business Overview
Table 137. Bethyl Laboratories CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 138. Bethyl Laboratories CD31 Antibody Product
Table 139. Bethyl Laboratories Recent Developments/Updates
Table 140. Abbexa Company Information
Table 141. Abbexa Description and Business Overview
Table 142. Abbexa CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 143. Abbexa CD31 Antibody Product
Table 144. Abbexa Recent Developments/Updates
Table 145. ProSci Company Information
Table 146. ProSci Description and Business Overview
Table 147. ProSci CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 148. ProSci CD31 Antibody Product
Table 149. ProSci Recent Developments/Updates
Table 150. Proteintech Company Information
Table 151. Proteintech Description and Business Overview
Table 152. Proteintech CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 153. Proteintech CD31 Antibody Product
Table 154. Proteintech Recent Developments/Updates
Table 155. Synaptic Systems Company Information
Table 156. Synaptic Systems Description and Business Overview
Table 157. Synaptic Systems CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 158. Synaptic Systems CD31 Antibody Product
Table 159. Synaptic Systems Recent Developments/Updates
Table 160. BIOCARE MEDICAL Company Information
Table 161. BIOCARE MEDICAL Description and Business Overview
Table 162. BIOCARE MEDICAL CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 163. BIOCARE MEDICAL CD31 Antibody Product
Table 164. BIOCARE MEDICAL Recent Developments/Updates
Table 165. CUSABIO Technology Company Information
Table 166. CUSABIO Technology Description and Business Overview
Table 167. CUSABIO Technology CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 168. CUSABIO Technology CD31 Antibody Product
Table 169. CUSABIO Technology Recent Developments/Updates
Table 170. Absolute Antibody Company Information
Table 171. Absolute Antibody Description and Business Overview
Table 172. Absolute Antibody CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 173. Absolute Antibody CD31 Antibody Product
Table 174. Absolute Antibody Recent Developments/Updates
Table 175. EpiGentek Company Information
Table 176. EpiGentek Description and Business Overview
Table 177. EpiGentek CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 178. EpiGentek CD31 Antibody Product
Table 179. EpiGentek Recent Developments/Updates
Table 180. Biorbyt Company Information
Table 181. Biorbyt Description and Business Overview
Table 182. Biorbyt CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 183. Biorbyt CD31 Antibody Product
Table 184. Biorbyt Recent Developments/Updates
Table 185. Wuhan Fine Biotech Company Information
Table 186. Wuhan Fine Biotech Description and Business Overview
Table 187. Wuhan Fine Biotech CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 188. Wuhan Fine Biotech CD31 Antibody Product
Table 189. Wuhan Fine Biotech Recent Developments/Updates
Table 190. Sino Biological Company Information
Table 191. Sino Biological Description and Business Overview
Table 192. Sino Biological CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 193. Sino Biological CD31 Antibody Product
Table 194. Sino Biological Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. CD31 Antibody Distributors List
Table 198. CD31 Antibody Customers List
Table 199. CD31 Antibody Market Trends
Table 200. CD31 Antibody Market Drivers
Table 201. CD31 Antibody Market Challenges
Table 202. CD31 Antibody Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of CD31 Antibody
Figure 2. Global CD31 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD31 Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global CD31 Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global CD31 Antibody Market Share by Application: 2024 & 2031
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Western Blot (WB)
Figure 11. Immunocytochemistry (ICC)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global CD31 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global CD31 Antibody Market Size (2020-2031) & (US$ Million)
Figure 16. Global CD31 Antibody Sales (2020-2031) & (L)
Figure 17. Global CD31 Antibody Average Price (US$/L) & (2020-2031)
Figure 18. CD31 Antibody Report Years Considered
Figure 19. CD31 Antibody Sales Share by Manufacturers in 2024
Figure 20. Global CD31 Antibody Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest CD31 Antibody Players: Market Share by Revenue in CD31 Antibody in 2024
Figure 22. CD31 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global CD31 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America CD31 Antibody Sales Market Share by Country (2020-2031)
Figure 25. North America CD31 Antibody Revenue Market Share by Country (2020-2031)
Figure 26. United States CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe CD31 Antibody Sales Market Share by Country (2020-2031)
Figure 29. Europe CD31 Antibody Revenue Market Share by Country (2020-2031)
Figure 30. Germany CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific CD31 Antibody Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific CD31 Antibody Revenue Market Share by Region (2020-2031)
Figure 37. China CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America CD31 Antibody Sales Market Share by Country (2020-2031)
Figure 45. Latin America CD31 Antibody Revenue Market Share by Country (2020-2031)
Figure 46. Mexico CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa CD31 Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa CD31 Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of CD31 Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of CD31 Antibody by Type (2020-2031)
Figure 56. Global CD31 Antibody Price (US$/L) by Type (2020-2031)
Figure 57. Global Sales Market Share of CD31 Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of CD31 Antibody by Application (2020-2031)
Figure 59. Global CD31 Antibody Price (US$/L) by Application (2020-2031)
Figure 60. CD31 Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global CD31 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global CD31 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global CD31 Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global CD31 Antibody Sales (L) of Key Manufacturers (2020-2025)
Table 5. Global CD31 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global CD31 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global CD31 Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market CD31 Antibody Average Price (US$/L) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of CD31 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CD31 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD31 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of CD31 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD31 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD31 Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD31 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global CD31 Antibody Sales by Region (2020-2025) & (L)
Table 18. Global CD31 Antibody Sales Market Share by Region (2020-2025)
Table 19. Global CD31 Antibody Sales by Region (2026-2031) & (L)
Table 20. Global CD31 Antibody Sales Market Share by Region (2026-2031)
Table 21. Global CD31 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global CD31 Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global CD31 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global CD31 Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America CD31 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America CD31 Antibody Sales by Country (2020-2025) & (L)
Table 27. North America CD31 Antibody Sales by Country (2026-2031) & (L)
Table 28. North America CD31 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America CD31 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe CD31 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe CD31 Antibody Sales by Country (2020-2025) & (L)
Table 32. Europe CD31 Antibody Sales by Country (2026-2031) & (L)
Table 33. Europe CD31 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe CD31 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific CD31 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific CD31 Antibody Sales by Region (2020-2025) & (L)
Table 37. Asia Pacific CD31 Antibody Sales by Region (2026-2031) & (L)
Table 38. Asia Pacific CD31 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific CD31 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD31 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America CD31 Antibody Sales by Country (2020-2025) & (L)
Table 42. Latin America CD31 Antibody Sales by Country (2026-2031) & (L)
Table 43. Latin America CD31 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America CD31 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa CD31 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa CD31 Antibody Sales by Country (2020-2025) & (L)
Table 47. Middle East and Africa CD31 Antibody Sales by Country (2026-2031) & (L)
Table 48. Middle East and Africa CD31 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa CD31 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global CD31 Antibody Sales (L) by Type (2020-2025)
Table 51. Global CD31 Antibody Sales (L) by Type (2026-2031)
Table 52. Global CD31 Antibody Sales Market Share by Type (2020-2025)
Table 53. Global CD31 Antibody Sales Market Share by Type (2026-2031)
Table 54. Global CD31 Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global CD31 Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global CD31 Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global CD31 Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global CD31 Antibody Price (US$/L) by Type (2020-2025)
Table 59. Global CD31 Antibody Price (US$/L) by Type (2026-2031)
Table 60. Global CD31 Antibody Sales (L) by Application (2020-2025)
Table 61. Global CD31 Antibody Sales (L) by Application (2026-2031)
Table 62. Global CD31 Antibody Sales Market Share by Application (2020-2025)
Table 63. Global CD31 Antibody Sales Market Share by Application (2026-2031)
Table 64. Global CD31 Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global CD31 Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global CD31 Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global CD31 Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global CD31 Antibody Price (US$/L) by Application (2020-2025)
Table 69. Global CD31 Antibody Price (US$/L) by Application (2026-2031)
Table 70. BosterBio Company Information
Table 71. BosterBio Description and Business Overview
Table 72. BosterBio CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. BosterBio CD31 Antibody Product
Table 74. BosterBio Recent Developments/Updates
Table 75. Bio-Rad Company Information
Table 76. Bio-Rad Description and Business Overview
Table 77. Bio-Rad CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. Bio-Rad CD31 Antibody Product
Table 79. Bio-Rad Recent Developments/Updates
Table 80. Bioss Company Information
Table 81. Bioss Description and Business Overview
Table 82. Bioss CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Bioss CD31 Antibody Product
Table 84. Bioss Recent Developments/Updates
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific CD31 Antibody Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. NSJ Bioreagents Company Information
Table 91. NSJ Bioreagents Description and Business Overview
Table 92. NSJ Bioreagents CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 93. NSJ Bioreagents CD31 Antibody Product
Table 94. NSJ Bioreagents Recent Developments/Updates
Table 95. R and D Systems Company Information
Table 96. R and D Systems Description and Business Overview
Table 97. R and D Systems CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 98. R and D Systems CD31 Antibody Product
Table 99. R and D Systems Recent Developments/Updates
Table 100. Abcam Company Information
Table 101. Abcam Description and Business Overview
Table 102. Abcam CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 103. Abcam CD31 Antibody Product
Table 104. Abcam Recent Developments/Updates
Table 105. BioLegend Company Information
Table 106. BioLegend Description and Business Overview
Table 107. BioLegend CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 108. BioLegend CD31 Antibody Product
Table 109. BioLegend Recent Developments/Updates
Table 110. GeneTex Company Information
Table 111. GeneTex Description and Business Overview
Table 112. GeneTex CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 113. GeneTex CD31 Antibody Product
Table 114. GeneTex Recent Developments/Updates
Table 115. Novus Biologicals Company Information
Table 116. Novus Biologicals Description and Business Overview
Table 117. Novus Biologicals CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 118. Novus Biologicals CD31 Antibody Product
Table 119. Novus Biologicals Recent Developments/Updates
Table 120. SouthernBiotech Company Information
Table 121. SouthernBiotech Description and Business Overview
Table 122. SouthernBiotech CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 123. SouthernBiotech CD31 Antibody Product
Table 124. SouthernBiotech Recent Developments/Updates
Table 125. LifeSpan BioSciences Company Information
Table 126. LifeSpan BioSciences Description and Business Overview
Table 127. LifeSpan BioSciences CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 128. LifeSpan BioSciences CD31 Antibody Product
Table 129. LifeSpan BioSciences Recent Developments/Updates
Table 130. Enzo Life Sciences Company Information
Table 131. Enzo Life Sciences Description and Business Overview
Table 132. Enzo Life Sciences CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 133. Enzo Life Sciences CD31 Antibody Product
Table 134. Enzo Life Sciences Recent Developments/Updates
Table 135. Bethyl Laboratories Company Information
Table 136. Bethyl Laboratories Description and Business Overview
Table 137. Bethyl Laboratories CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 138. Bethyl Laboratories CD31 Antibody Product
Table 139. Bethyl Laboratories Recent Developments/Updates
Table 140. Abbexa Company Information
Table 141. Abbexa Description and Business Overview
Table 142. Abbexa CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 143. Abbexa CD31 Antibody Product
Table 144. Abbexa Recent Developments/Updates
Table 145. ProSci Company Information
Table 146. ProSci Description and Business Overview
Table 147. ProSci CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 148. ProSci CD31 Antibody Product
Table 149. ProSci Recent Developments/Updates
Table 150. Proteintech Company Information
Table 151. Proteintech Description and Business Overview
Table 152. Proteintech CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 153. Proteintech CD31 Antibody Product
Table 154. Proteintech Recent Developments/Updates
Table 155. Synaptic Systems Company Information
Table 156. Synaptic Systems Description and Business Overview
Table 157. Synaptic Systems CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 158. Synaptic Systems CD31 Antibody Product
Table 159. Synaptic Systems Recent Developments/Updates
Table 160. BIOCARE MEDICAL Company Information
Table 161. BIOCARE MEDICAL Description and Business Overview
Table 162. BIOCARE MEDICAL CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 163. BIOCARE MEDICAL CD31 Antibody Product
Table 164. BIOCARE MEDICAL Recent Developments/Updates
Table 165. CUSABIO Technology Company Information
Table 166. CUSABIO Technology Description and Business Overview
Table 167. CUSABIO Technology CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 168. CUSABIO Technology CD31 Antibody Product
Table 169. CUSABIO Technology Recent Developments/Updates
Table 170. Absolute Antibody Company Information
Table 171. Absolute Antibody Description and Business Overview
Table 172. Absolute Antibody CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 173. Absolute Antibody CD31 Antibody Product
Table 174. Absolute Antibody Recent Developments/Updates
Table 175. EpiGentek Company Information
Table 176. EpiGentek Description and Business Overview
Table 177. EpiGentek CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 178. EpiGentek CD31 Antibody Product
Table 179. EpiGentek Recent Developments/Updates
Table 180. Biorbyt Company Information
Table 181. Biorbyt Description and Business Overview
Table 182. Biorbyt CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 183. Biorbyt CD31 Antibody Product
Table 184. Biorbyt Recent Developments/Updates
Table 185. Wuhan Fine Biotech Company Information
Table 186. Wuhan Fine Biotech Description and Business Overview
Table 187. Wuhan Fine Biotech CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 188. Wuhan Fine Biotech CD31 Antibody Product
Table 189. Wuhan Fine Biotech Recent Developments/Updates
Table 190. Sino Biological Company Information
Table 191. Sino Biological Description and Business Overview
Table 192. Sino Biological CD31 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 193. Sino Biological CD31 Antibody Product
Table 194. Sino Biological Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. CD31 Antibody Distributors List
Table 198. CD31 Antibody Customers List
Table 199. CD31 Antibody Market Trends
Table 200. CD31 Antibody Market Drivers
Table 201. CD31 Antibody Market Challenges
Table 202. CD31 Antibody Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of CD31 Antibody
Figure 2. Global CD31 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD31 Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global CD31 Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global CD31 Antibody Market Share by Application: 2024 & 2031
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Western Blot (WB)
Figure 11. Immunocytochemistry (ICC)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global CD31 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global CD31 Antibody Market Size (2020-2031) & (US$ Million)
Figure 16. Global CD31 Antibody Sales (2020-2031) & (L)
Figure 17. Global CD31 Antibody Average Price (US$/L) & (2020-2031)
Figure 18. CD31 Antibody Report Years Considered
Figure 19. CD31 Antibody Sales Share by Manufacturers in 2024
Figure 20. Global CD31 Antibody Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest CD31 Antibody Players: Market Share by Revenue in CD31 Antibody in 2024
Figure 22. CD31 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global CD31 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America CD31 Antibody Sales Market Share by Country (2020-2031)
Figure 25. North America CD31 Antibody Revenue Market Share by Country (2020-2031)
Figure 26. United States CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe CD31 Antibody Sales Market Share by Country (2020-2031)
Figure 29. Europe CD31 Antibody Revenue Market Share by Country (2020-2031)
Figure 30. Germany CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific CD31 Antibody Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific CD31 Antibody Revenue Market Share by Region (2020-2031)
Figure 37. China CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America CD31 Antibody Sales Market Share by Country (2020-2031)
Figure 45. Latin America CD31 Antibody Revenue Market Share by Country (2020-2031)
Figure 46. Mexico CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa CD31 Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa CD31 Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE CD31 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of CD31 Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of CD31 Antibody by Type (2020-2031)
Figure 56. Global CD31 Antibody Price (US$/L) by Type (2020-2031)
Figure 57. Global Sales Market Share of CD31 Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of CD31 Antibody by Application (2020-2031)
Figure 59. Global CD31 Antibody Price (US$/L) by Application (2020-2031)
Figure 60. CD31 Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232